Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ILiAD Biotechnologies

ILiAD Biotechnologies
2012 FOUNDED
PRIVATE STATUS
Later Stage VC LATEST DEAL TYPE (In Progress)
$3.4M LATEST DEAL AMOUNT
5 INVESTORS
Description

Owner and operator of a biotechnology company intended to prevent and offer treatment of human disease caused by Bordetella pertussis. The company's services mainly focus on offering treatment for Alzheimer's disease, allergic disease, autoimmune disease and is focused on producing a live attenuated pertussis vaccine, enabling clients to eradicate whooping cough by developing an improved pertussis vaccine.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 4581 Weston Road
  • Suite 260
  • Weston, FL 33331
  • United States

+1 (917) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ILiAD Biotechnologies’s full profile, request a free trial.

ILiAD Biotechnologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 20-Nov-2019 $3.4M 000.00 In Progress Clinical Trials - Phase 2
6. Later Stage VC (Series C) 19-Dec-2018 000.00 000.00 Completed Clinical Trials - Phase 2
5. Angel (individual) 07-Feb-2018 00000 000.00 Completed Clinical Trials - Phase 1
4. Angel (individual) 13-Apr-2017 000 000.00 Completed Clinical Trials - Phase 1
3. Angel (individual) 13-Nov-2015 00000 00.000 Completed Clinical Trials - Phase 1
2. Grant $10M $3.81M Completed Clinical Trials - Phase 1
1. Angel (individual) $3.81M $3.81M Completed Clinical Trials - Phase 1
To view this company’s complete deal history including valuation and funding, request access »

ILiAD Biotechnologies Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JEMS venture capital Venture Capital Minority 000 0000 000000 0
Network-1 Technologies Corporation Minority 000 0000 000000 0
SDS Capital Hedge Fund Minority 000 0000 000000 0
Seedlings Life Science Ventures Corporation Minority 000 0000 000000 0
European Union Government 000 0000 000000 0

ILiAD Biotechnologies Executive Team (4)

Name Title Board
Seat
Contact
Info
Keith Rubin MD Founder, Chief Executive Officer & Board Member
Ken Solovay Chief Operating Officer
Cheryl Keech Ph.D Chief Medical Officer
Walter Greenblatt Chief Financial Officer

ILiAD Biotechnologies Board Members (5)

Name Representing Role Since Contact
Info
Ariel Pablos-Mendez MD ILiAD Biotechnologies Board Member 000 0000
Bin Yan Ph.D ILiAD Biotechnologies Board Member 000 0000
Corey Horowitz Network-1 Technologies Board Member 000 0000
Cuong Do ILiAD Biotechnologies Board Member 000 0000
Keith Rubin MD ILiAD Biotechnologies Founder, Chief Executive Officer & Board Member 000 0000